Replies to post #727532 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Who has done that? Certainly not this scam. It's done by successful clinical trials of which NWBO has run none. It's not done by anonymous posters.

Guess the definition of zero ORR escapes you.

[dennisdave]

I will answer that. IF DCVAX were to be approved for all solid tumors. And that is a HUGE IF

Then DCVAX could follow the same path as GenMab
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer. Genmab has 8 (FDA) approved therapies incorporating Genmab innovation and 20 Products in clinical development incorporating Genmab innovation

ELEVEN of the 20 Products in clinical development are medical trials for different types of solid tumors of which a couple for all solid tumors. You can find them here. https://www.genmab.com/antibody-science/pipeline The solid tumor medical trials are being conducted with approved drugs. Interm results are looking very promising.

According to Genmab's latest financial reports, the company's current revenue (TTM ) is $2.74 Billion USD. Yet Genmab's market cap as of October 2024 is only $14.46 Billion USD.

But sure NWBO's market cap will get to 1 trillion. Dont let reality get in the way of fairytale stories.
Yeah yeah yeah DCVAX is so much better than all the other immu therapies that the market will reward NWBO with $ trillions

Fantasy, insanity (that rhymes)